To evaluate the clinical utility of DANCR, we evaluated several existing diagnostic indicators including serum CEA and CA199 in the CRC patients and found no significant difference in serum CEA and CA199 between the CRC patients and the normal controls (P>0.05) (Figure 3A,B). Here, CEACAM5 is linked to colorectal carcinoma.